Algert Global LLC Puma Biotechnology, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.64 - $3.3 $10,315 - $20,757
6,290 Added 15.02%
48,178 $137,000
Q1 2022

May 16, 2022
BUY
$2.13 - $3.24 $30,735 - $46,753
14,430 Added 52.55%
41,888 $121,000
Q4 2021

Feb 14, 2022
BUY
$2.85 - $6.58 $25,279 - $58,364
8,870 Added 47.72%
27,458 $83,000
Q3 2021

Nov 15, 2021
BUY
$6.63 - $9.39 $123,238 - $174,541
18,588 New
18,588 $130,000

Others Institutions Holding PBYI

# of Institutions
102
Shares Held
29M
Call Options Held
60.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $138M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email